ArticleActa pharmacologica Sinica2014

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells.

Chang-xi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.